concept

CLDN1, OCLN, ZO1, MLCK

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CLDN1, OCLN, ZO1, MLCK: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

15Connections
1Hypotheses
1Analyses
11Outgoing
4Incoming
10Experiments
1Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameCLDN1, OCLN, ZO1, MLCK
Key Genes/ProteinsAHR, IL10, TGFB1, GLP1R, GLP1R, BDNF, NLRP3, NLRP3, CASP1, IL1B, PYCARD, SNCA, HSPA1A, DNMT1
Related Diseasesneurodegeneration

Pathway Diagram

graph TD
    CLDN1__OCLN__ZO1__MLCK[CLDN1, OCLN, ZO1, MLCK]
    CLDN1__OCLN__ZO1__MLCK -->|debate_co_mention| GLP1R[GLP1R]
    CLDN1__OCLN__ZO1__MLCK -->|debate_co_mention| GLP1R__BDNF[GLP1R, BDNF]
    CLDN1__OCLN__ZO1__MLCK -->|debate_co_mention| neuroinflammation[neuroinflammation]
    CLDN1__OCLN__ZO1__MLCK -->|debate_co_mention| NLRP3[NLRP3]
    CLDN1__OCLN__ZO1__MLCK -->|implicated in| neurodegeneration[neurodegeneration]
    CLDN1__OCLN__ZO1__MLCK -->|co_associated_with| SNCA__HSPA1A__DNMT1[SNCA, HSPA1A, DNMT1]
    CLDN1__OCLN__ZO1__MLCK -->|co_associated_with| TH__AADC[TH, AADC]
    CLDN1__OCLN__ZO1__MLCK -->|co_associated_with| NLRP3__CASP1__IL1B__PYCARD[NLRP3, CASP1, IL1B, PYCARD]
    CLDN1__OCLN__ZO1__MLCK -->|co_associated_with| TLR4__SNCA[TLR4, SNCA]
    h_6c83282d[h-6c83282d] -->|targets| CLDN1__OCLN__ZO1__MLCK
    AHR__IL10__TGFB1[AHR, IL10, TGFB1] -->|debate_co_mention| CLDN1__OCLN__ZO1__MLCK
    benchmark_ot_ad_answer_key_CLD[benchmark_ot_ad_answer_key:CLDN1, OCLN, ZO1, MLCK] -->|data_in| CLDN1__OCLN__ZO1__MLCK

Outgoing (11)

TargetRelationTypeStr
benchmark_ot_ad_answer_key:CLDN1, OCLN, ZO1, MLCKdata_indataset_row0.00
GLP1Rdebate_co_mentiongene0.45
GLP1R, BDNFdebate_co_mentiongene0.45
neuroinflammationdebate_co_mentionprocess0.45
NLRP3debate_co_mentiongene0.45

Incoming (4)

SourceRelationTypeStr
benchmark_ot_ad_answer_key:CLDN1, OCLN, ZO1, MLCKdata_indataset_row0.00
h-6c83282dtargetshypothesis0.50
AHR, IL10, TGFB1debate_co_mentiongene0.45
AHR, IL10, TGFB1co_associated_withgene0.40

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Gut Barrier Permeability-α-Synuclein Axis Modulation 0.533 neurodegeneration What are the mechanisms by which gut mic

Mentioning Analyses (1)

Scientific analyses that reference this entity

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

neurodegeneration | 2026-04-01 | 13 hypotheses Top: 0.888

Experiments (10)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Alpha-Synuclein SAA Kinetics Study — Biological Staging Backbone for P clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiation Mechanis clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Computational Modeling of Alpha-Synuclein Propagation in PD validation Parkinson's Disease 0.400 0.50 human proposed $2,280,000
Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation validation Parkinson's Disease 0.400 0.50 human proposed $2,730,000
Alpha-Synuclein Seed Amplification Assay Validation clinical Parkinson's Disease 0.400 0.50 human proposed $7,500,000
Antiviral Therapy Trial for Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Alpha-Synuclein Staging and Spreading in DLB — Spatial Propagation Map validation Parkinson's Disease 0.400 0.50 cell_line proposed $160,000
Genetic Risk Modifiers in DLB Phenotype clinical Neurodegeneration 0.400 0.50 human proposed $7,500,000
Tau Co-Pathology in DLB Clinical Heterogeneity clinical Neurodegeneration 0.400 0.50 human proposed $5,460,000
Gut-Brain Axis Pathogenesis in Parkinson's Disease — Mechanism and Int clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Betulinic Acid Reduces Intestinal Inflammation and Enhances Intestinal Tight Jun [PMID:40647158] ["Zheng X", "Cao Z", "Wang M", "Yuan R", Nutrients 2025 1
Claudins proteins in brain tumors: expression patterns and therapeutic target. [PMID:41399659] ["Romanowicz A", "\u0141ukaszewicz-Zaj\u Biochemia medica 2026 0
Lonicerae flos and turmeric extracts alleviate necrotic enteritis in broilers by [PMID:40781642] ["Liu X", "Ji Y", "Lv H", "Wang Z", "Lv Journal of animal science and 2025 0
Lianweng formula restores intestinal barrier function in ulcerative colitis thro [PMID:40815948] ["Lv J", "Fu Y", "Huang S", "Han C", "Zh Phytomedicine : international 2025 0
Microbiota-gut-brain axis in neurodegenerative diseases: molecular mechanisms an [PMID:40952592] ["Chen C", "Wang G", "Li D", "Zhang F"] Molecular biomedicine 2025 0
Engineered Probiotics Enable Targeted Gut Delivery of Dual Gasotransmitters for [PMID:40091878] ["Ma T", "Gan G", "Cheng J", "Shen Z", " Angewandte Chemie (Internation 2025 0
Claudin-1 impairs blood-brain barrier by downregulating endothelial junctional p [PMID:40018968] Gowrikumar S, Tarudji A, McDonald BZ, Ba Tissue barriers 2025 0
Fermented Soy Protein Maillard Product Prevents Bone Loss via TNF-α Suppression [PMID:41466098] ["Bae H", "Joung J", "Choi H", "Han J", Journal of microbiology and bi 2025 0
Transcriptional dysregulation of skin barrier genes in atopic dermatitis and pso [PMID:40885142] ["Che-Wen Y", "Lin F", "Chen K", "Cheng Biomedicine & pharmacotherapy 2025 0
Zn glycine mitigates the LPS-induced hepatic injury and inflammation through NrF [PMID:40957293] ["Zulfiqar Z", "Asif M", "Al-Mitib L", " Poultry science 2025 0
Traditional Chinese herbal medicines for the treatment of ischemic stroke in Chi [PMID:40516828] ["Dong X", "Zhang T", "Zhang C", "Shang Ageing research reviews 2025 0
Polystyrene microplastic-induced oxidative stress triggers intestinal barrier dy [PMID:38301820] Zeng G, Li J, Wang Y, Su J, Lu Z, Zhang Environmental pollution (Barki 2024 0
Acrolein suppresses anticancer drug-induced toxicity mediated by activating clau [PMID:38142011] ["Eguchi H", "Yu Y", "Matsunaga T", "Yos Toxicology letters 2024 0
Exposure to Progestin 17-OHPC Induces Gastrointestinal Dysfunction through Claud [PMID:38583420] ["Zeng L", "Zhang X", "Shen Q", "He L", Neuroendocrinology 2024 0
Untitled [PMID:37492530] ["Lei W", "Cheng Y", "Gao J", "Liu X", " Frontiers in cellular and infe 2023 0
Effects of prebiotics on intestinal physiology, neuropsychological function, and [PMID:36869551] ["Chung Y", "Wu J", "Huang W"] Food research international (O 2023 0
The Role of Gut Dysbiosis in the Pathophysiology of Neuropsychiatric Disorders. [PMID:36611848] ["Anand N", "Gorantla V", "Chidambaram S Cells 2022 0
Mammary tumors alter the fecal bacteriome and permit enteric bacterial transloca [PMID:35248004] ["Loman B", "Russart K", "Grant C", "Lyn BMC cancer 2022 0
Co-exposure to boscalid and TiO [PMID:35559963] ["Cao X", "Khare S", "DeLoid G", "Gokula NanoImpact 2021 0
Co-exposure to boscalid and TiO [PMID:33869896] ["Cao X", "Khare S", "DeLoid G", "Gokula NanoImpact 2021 0

Debates (1)

Multi-agent debates referencing this entity

What are the mechanisms underlying what are the mechanisms by which gut microbio

closed · Rounds: 4 · Score: 0.95 · 2026-04-01

Related Research

Hypotheses and analyses mentioning CLDN1, OCLN, ZO1, MLCK in their description or question text

No additional research found